Early research (Phase 1)Ended earlyNCT04406857
What this trial is testing
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Who this might be right for
Locally Advanced Rectal CarcinomaRectal AdenocarcinomaStage II Rectal Cancer AJCC v8+1 more
National Cancer Institute (NCI) 1